Official NIH NLM MEDLINE / PubMed Citation • PMID: 42493571
Povorcitinib for hidradenitis suppurativa: the randomized, double-blind, placebo-controlled STOP-HS1 and STOP-HS2 phase 3 trials.
Nat Med
Verbatim Formal Study Abstract
ClinicalTrials.gov registration: NCT05620823 and NCT05620836 .